Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP.
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood.2019003646
Abstract: Polyclonal anti-D is a first line therapy for immune thrombocytopenia (ITP). Monoclonal antibodies are desirable alternatives, but none have yet proven successful despite their ability to opsonize erythrocytes and cause anemia. Here we examined twelve… read more here.
Keywords: platelet phagocytosis; ability; phagocytosis; phagocytosis vitro ... See more keywords